Cloning/Embryonic Stem Cells
The term cloning is used by scientists to describe many different processes that involve making duplicates of biological material. In most cases, isolated genes or cells are duplicated for scientific study, and no new animal results. The experiment that led to the cloning of Dolly the sheep in 1997 was different: It used a cloning technique called somatic cell nuclear transfer and resulted in an animal that was a genetic twin -- although delayed in time -- of an adult sheep. This technique can also be used to produce an embryo from which cells called embryonic stem (ES) cells could be extracted to use in research into potential therapies for a wide variety of diseases.
Thus, in the past five years, much of the scientific and ethical debate about somatic cell nuclear transfer has focused on its two potential applications: 1) for reproductive purposes, i.e., to produce a child, or 2) for producing a source of ES cells for research.
The technique of transferring a nucleus from a somatic cell into an egg that produced Dolly was an extension of experiments that had been ongoing for over 40 years. In the simplest terms, the technique used to produce Dolly the sheep - somatic cell nuclear transplantation cloning - involves removing the nucleus of an egg and replacing it with the diploid nucleus of a somatic cell. Unlike sexual reproduction, during which a new organism is formed when the genetic material of the egg and sperm fuse, in nuclear transplantation cloning there is a single genetic "parent." This technique also differs from previous cloning techniques because it does not involve an existing embryo. Dolly is different because she is not genetically unique; when born she was genetically identical to an existing six-year-old ewe. Although the birth of Dolly was lauded as a success, in fact, the procedure has not been perfected and it is not yet clear whether Dolly will remain healthy or whether she is already experiencing subtle problems that might lead to serious diseases. Thus, the prospect of applying this technique in humans is troubling for scientific and safety reasons in addition to a variety of ethical reasons related to our ideas about the natural ordering of family and successive generations.
Several important concerns remain about the science and safety of nuclear transfer cloning using adult cells as the source of nuclei. To date, five mammalian species -- sheep, cattle, pigs, goats, and mice -- have been used extensively in reproductive cloning studies. Data from these experiments illustrate the problems involved. Typically, very few cloning attempts are successful. Many cloned animals die in utero, even at late stages or soon after birth, and those that survive frequently exhibit severe birth defects. In addition, female animals carrying cloned fetuses may face serious risks, including death from cloning-related complications.
An additional concern focuses on whether cellular aging will affect the ability of somatic cell nuclei to program normal development. As somatic cells divide they progressively age, and there is normally a defined number of cell divisions that can occur before senescence. Thus, the health effects for the resulting liveborn, having been created with an "aged" nucleus, are unknown. Recently it was reported that Dolly has arthritis, although it is not yet clear whether the five-and-a-half-year-old sheep is suffering from the condition as a result of the cloning process. And, scientists in Tokyo have shown that cloned mice die significantly earlier than those that are naturally conceived, raising an additional concern that the mutations that accumulate in somatic cells might affect nuclear transfer efficiency and lead to cancer and other diseases in offspring. Researchers working with clones of a Holstein cow say genetic programming errors may explain why so many cloned animals die, either as fetuses or newborns.
The announcement of Dolly sparked widespread speculation about a human child being created using somatic cell nuclear transfer. Much of the perceived fear that greeted this announcement centered on the misperception that a child or many children could be produced who would be identical to an already existing person. This fear is based on the idea of "genetic determinism" -- that genes alone determine all aspects of an individual -- and reflects the belief that a person's genes bear a simple relationship to the physical and psychological traits that compose that individual. Although genes play an essential role in the formation of physical and behavioral characteristics, each individual is, in fact, the result of a complex interaction between his or her genes and the environment within which he or she develops. Nonetheless, many of the concerns about cloning have focused on issues related to "playing God," interfering with the natural order of life, and somehow robbing a future individual of the right to a unique identity.
Several groups have concluded that reproductive cloning of human beings creates ethical and scientific risks that society should not tolerate. In 1997, the National Bioethics Advisory Commission recommended that it was morally unacceptable to attempt to create a child using somatic cell nuclear transfer cloning and suggested that a moratorium be imposed until safety of this technique could be assessed. The commission also cautioned against preempting the use of cloning technology for purposes unrelated to producing a liveborn child.
Similarly, in 2001 the National Academy of Sciences issued a report stating that the United States should ban human reproductive cloning aimed at creating a child because experience with reproductive cloning in animals suggests that the process would be dangerous for the woman, the fetus, and the newborn, and would likely fail. The report recommended that the proposed ban on human cloning should be reviewed within five years, but that it should be reconsidered "only if a new scientific review indicates that the procedures are likely to be safe and effective, and if a broad national dialogue on societal, religious and ethical issues suggests that reconsideration is warranted." The panel concluded that the scientific and medical considerations that justify a ban on human reproductive cloning at this time do not apply to nuclear transplantation to produce stem cells. Several other scientific and medical groups also have stated their opposition to the use of cloning for the purpose of producing a child.
The cloning debate was reopened with a new twist late in 1998, when two scientific reports were published regarding the successful isolation of human stem cells. Stem cells are unique and essential cells found in animals that are capable of continually reproducing themselves and renewing tissue throughout an individual organism's life. ES cells are the most versatile of all stem cells because they are less differentiated, or committed, to a particular function than adult stem cells. These cells have offered hope of new cures to debilitating and even fatal illness. Recent studies in mice and other animals have shown that ES cells can reduce symptoms of Parkinson's disease in mouse models, and work in other animal models and disease areas seems promising.
In the 1998 reports, ES cells were derived from in vitro embryos six to seven days old destined to be discarded by couples undergoing infertility treatments, and embryonic germ (EG) cells were obtained from cadaveric fetal tissue following elective abortion. A third report, appearing in the New York Times, claimed that a Massachusetts biotechnology company had fused a human cell with an enucleated cow egg, creating a hybrid clone that failed to progress beyond an early stage of development. This announcement served as a reminder that ES cells also could be derived from embryos created through somatic cell nuclear transfer, or cloning. In fact, several scientists believed that deriving ES cells in this manner is the most promising approach to developing treatments because the condition of in vitro fertilization (IVF) embryos stored over time is questionable and this type of cloning could overcome graft-host responses if resulting therapies were developed from the recipient's own DNA.
For those who believe that the embryo has the moral status of a person from the moment of conception, research or any other activity that would destroy it is wrong. For those who believe the human embryo deserves some measure of respect, but disagree that the respect due should equal that given to a fully formed human, it could be considered immoral not to use embryos that would otherwise be destroyed to develop potential cures for disease affecting millions of people. An additional concern related to public policy is whether federal funds should be used for research that some Americans find unethical.
Since 1996, Congress has prohibited researchers from using federal funds for human embryo research. In 1999, DHHS announced that it intended to fund research on human ES cells derived from embryos remaining after infertility treatments. This decision was based on an interpretation "that human embryonic stem cells are not a human embryo within the statutory definition" because "the cells do not have the capacity to develop into a human being even if transferred to the uterus, thus their destruction in the course of research would not constitute the destruction of an embryo." DHHS did not intend to fund research using stem cells derived from embryos created through cloning, although such efforts would be legal in the private sector.
In July 2001, the House of Representatives voted 265 to 162 to make any human cloning a criminal offense, including cloning to create an embryo for derivation of stem cells rather than to produce a child. In August 2002, President Bush, contending with a DHHS decision made during the Clinton administration, stated in a prime-time television address that federal support would be provided for research using a limited number of stem cell colonies already in existence (derived from leftover IVF embryos). Current bills before Congress would ban all forms of cloning outright, prohibit cloning for reproductive purposes, and impose a moratorium on cloning to derive stem cells for research, or prohibit cloning for reproductive purposes while allowing cloning for therapeutic purposes to go forward. As of late June, the Senate has taken no action. President Bush's Bioethics Council is expected to recommend the prohibition of reproductive cloning and a moratorium on therapeutic cloning later this summer.
Prepared by Kathi E. Hanna, M.S., Ph.D., Science and Health Policy Consultant
Last Reviewed: April 2006
Read the original here:
Cloning/Embryonic Stem Cells - National Human Genome ...
- Single C-to-T substitution using engineered APOBEC3G-nCas9 base editors with minimum genome- and transcriptome-wide off-target effects - Science... - July 15th, 2020
- Cell Therapy Processing Market is Booming Worldwide to Show Significant Growth by 2026 Cell Therapies Pty Ltd,Invitrx Inc.,Lonza Ltd,Merck & Co.,... - July 15th, 2020
- Tech: New material mimics strength, toughness of mother of pearl - Tdnews - July 15th, 2020
- Stem cell breakthrough: Japanese scientists discover way ... - July 14th, 2020
- Types of Stem Cells - July 14th, 2020
- What's next for Tony Fauci, if the White House continues to sour on him? - STAT - July 14th, 2020
- Why are scientists trying to manufacture organs in space? - Space.com - July 13th, 2020
- Cell Freezing Media for Cell Therapy Market with Covid-19 Pandemic Analysis, Growth Rate, New Trend Analysis & Forecast To 2026 | Key Players:... - July 13th, 2020
- Radiation Response of Murine Embryonic Stem Cells - July 9th, 2020
- Human Embryonic Stem Cells (HESC) Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News - July 9th, 2020
- Cell Therapy Market Analysis Of Global Trends, Demand And Competition 2020-2028 - Jewish Life News - July 9th, 2020
- Why we still haven't cloned humans it's not just ethics - Business Insider - Business Insider - July 9th, 2020
- COVID-19 Impact and Recovery Analysis on Cell Freezing Media for Cell Therapy Market 2020-2026 by BioLife Solutions, Akron Biotechnology, GE... - July 9th, 2020
- Cellular Analysis Market Promising Growth Opportunities and Forecast 2017-2025 - Owned - July 9th, 2020
- Why are scientists trying to manufacture organs in space? - The Conversation US - July 9th, 2020
- Stem Cell Characterization and Analysis Tool Market By Covid-19 Impact Analysis Volume and Value, Revenue, Business Opportunity, Future Projections,... - July 7th, 2020
- A novel system to map protein interactions reveals evolutionarily conserved immune evasion pathways on transmissible cancers - Science Advances - July 4th, 2020
- Tom Still: Will Tommy boost UW research? - La Crosse Tribune - July 1st, 2020
- Lab-grown mini-organs reveal the damage inflicted by Covid-19 - Health24 - June 30th, 2020
- Global Cell Isolation/Cell Separation Market Industry Analysis and Forecast (2019-2026) - Morning Tick - June 30th, 2020
- Cell Sorting Market 2020, Top Key Players, Trends, Size, Drivers, Policies, Applications And Competitive Landscape To 2027 - 3rd Watch News - June 26th, 2020
- Insight on the Growth of Autologous Stem Cell Based Therapies Market Growth with Challenges, Standardization, Competitive Market Share and Top Players... - June 26th, 2020
- How cancer cells resist radiotherapy - The Star Online - June 26th, 2020
- Stem Cell Bond Measure To Be Placed On November Ballot - California Globe - June 24th, 2020
- Trending: Autologous Stem Cell Based Therapies 2020: Global Size, Supply-Demand, Product Type and End User Analysis To 2026 - Weekly Wall - June 24th, 2020
- Global Regenerative Medicine Market Demands, Key Players, Growth, Size and Forecast with Impact of COVID-19 (2020-2024) - Jewish Life News - June 23rd, 2020
- COVID 19 to Lead the Sales of Adipose Tissue-derived Stem Cells to Register Stellar Growth in the Next 10 Years - Personal Injury Bureau UK - June 23rd, 2020
- Global Regenerative Medicine Market: Size and Forecast with Impact Analysis of COVID-19 (2020-2024) - Cole of Duty - June 23rd, 2020
- Outlook on the Worldwide Regenerative Medicine Industry to 2024 - Rising Global Healthcare Expenditure Presents Opportunities - Yahoo Finance - June 23rd, 2020
- Global Regenerative Medicine Market (2020 to 2024) - Size & Forecast with Impact Analysis of COVID-19 - ResearchAndMarkets.com - Business Wire - June 23rd, 2020
- PMR Reveals In-Depth Analysis On The Cell Banking Outsourcing Market 2016-2022 - The Canton Independent Sentinel - June 23rd, 2020
- Genome-wide kinetic properties of transcriptional bursting in mouse embryonic stem cells - Science Advances - June 19th, 2020
- Stem Cells Without Ethical Implications Are Ready for the Spotlight - Press Release - Digital Journal - June 19th, 2020
- Stem Cell Banking Market will Generate Massive Revenue to $6,956 million by 2023 | Cord Blood Registry, ViaCord, Cryo-Cell, China Cord Blood... - June 13th, 2020
- Study identifies mechanism affecting X chromosome that could lead to new disease therapies - Science Codex - June 12th, 2020
- Exploring the Therapeutic Potential of ST266 Against Numerous Diseases Including COVID-19 - Technology Networks - June 12th, 2020
- Cellular Reprogramming Tools Market to Witness Robust Expansion Throughout the F - News.MarketSizeForecasters.com - June 12th, 2020
- Assisted fertilization, the referendum 15 years ago - NJ MMA News - June 12th, 2020
- Growth in Sales of Cell Banking Outsourcing Market to Push Revenue Growth in the Market - The Canton Independent Sentinel - June 12th, 2020
- Explore the Mice Model Market: CRISPR As a Powerful Tool in the Field of BioMedical Research - WhaTech Technology and Markets News - June 12th, 2020
- Human Embryonic Stem Cells Market Size Detailed Analysis ... - June 12th, 2020
- Science News Roundup: Tiny 13,500-year-old bird statuette shows origins of Chinese art; World's largest green turtle colony nearly twice as big as... - June 12th, 2020
- Sales Revenue of Adipose Tissue-derived Stem Cells to Increase in Coming 10 years on Back of Rapid Adoption Across Major Industries Medic Report -... - June 9th, 2020
- Global Stem Cells Market 2020 (COVID-19) Impact Analysis: Business Trends, Growth Insight, Statistics And Forecast to 2025 - Surfacing Magazine - June 9th, 2020
- Microglia: the brains 'immune cells' protect against diseases but they can also cause them - The Conversation UK - June 1st, 2020
- 1st transplant using liver cells from embryonic stem cells conducted on baby in Japan - The Mainichi - May 26th, 2020
- Global Stem Cell Reconstructive Market- Industry Analysis and Forecast... - Azizsalon News - May 26th, 2020
- Anti-Aging: HGH Can Reduce Biological Age by One Year and a Half Study Shows - Gilmore Health News - May 26th, 2020
- Stem Cell Therapy Market by Treatment,Application,End Users and Geography Forecast To... - Azizsalon News - May 21st, 2020
- Georgetown student takes Islamic bioethics research at QF to Washington and wins - Gulf Times - May 21st, 2020
- Dose-dependent functions of SWI/SNF BAF in permitting and inhibiting cell proliferation in vivo - Science Advances - May 21st, 2020
- Human Embryonic Stem Cells (HESC) Market to witness an impressive growth during - News by aeresearch - May 20th, 2020
- Qatar- Georgetown student takes Islamic bioethics research at QF to Washington and wins - MENAFN.COM - May 15th, 2020
- Millions of Human Cells Have Been Grown Inside Mice Embryos - Newsweek - May 14th, 2020
- AgeX Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update - Business Wire - May 14th, 2020
- Human Embryonic Stem Cells (HESC) Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 - Cole of Duty - May 14th, 2020
- The Cell Therapy Industry to 2028: Global Market & Technology Analysis, Company Profiles of 309 Players (170 Involved in Stem Cells) -... - May 14th, 2020
- 2025 Projections: Cell Freezing Media for Cell Therapy Market Report by Type, Application and Regional Outlook - AlgosOnline - May 14th, 2020
- Tolero Pharmaceuticals Announces Expansion of the Zella 102 Study in Patients with Intermediate and High-Risk Myelodysplastic Syndromes (MDS) - The... - May 14th, 2020
- Strides in Medical Tourism Market Key Driver of Low-cost Patient Care in Globalized Healthcare Systems, Notes TMR - Stockhouse - May 14th, 2020
- Uses and Abuses of Scientific Consensus - National Review - May 13th, 2020
- Lineage Cell Therapeutics Reports New Data With OpRegen for the Treatment of Dry AMD With Geographic Atrophy - Business Wire - May 13th, 2020
- COVID-19 Impact on STEM CELL THERAPY MARKET 2020 TO 2027-EXPANDING WORLDWIDE WITH TOP PLAYERS FUTURE BUSINESS SCOPE AND INVESTMENT ANALYSIS REPORT -... - May 13th, 2020
- Human Embryonic Stem Cells (HESC) Market 2020 | Growth Drivers, Challenges, Trends, Market Dynamics and Forecast to 2026 - Cole of Duty - May 10th, 2020
- Louis Bacon Is Having The Time Of His Life - Dealbreaker - May 10th, 2020
- Lineage Cell Therapeutics Reports New Data With OpRegen for the Treatment of Dry AMD With Geographic Atrophy - Yahoo Finance - May 10th, 2020
- Human Embryonic Stem Cells, Germ Cells, and Cell-Derived ... - May 7th, 2020
- Inside the twisted world of 'rapist' designer Peter Nygard: book - The Loppy - May 4th, 2020
- Lack of investment is the biggest challenge in stem cell research - Express Healthcare - May 2nd, 2020
- AgeX Therapeutics: Revolutionary Potential But Extremely Early - Seeking Alpha - April 30th, 2020
- Human Embryonic Stem Cells (HESC) Market Overview, Top Companies, Region, Application and Global Forecast by 2026 - Latest Herald - April 27th, 2020
- Role of MyHC-embryonic protein in muscle development and disease - Tech Explorist - April 27th, 2020
- The Republicans who were once so pro-life they fought over one woman on life support now want to sacrifice grandma for the economy - The Independent - April 26th, 2020
- Sustainably Yours: The importance of understanding and trusting in Science - The Phuket News - April 26th, 2020
- Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify's iPSC- and ESC-derived regulatory T cells - SelectScience - April 24th, 2020
- Stem Cell Therapy Market Research Outlook, Recent Trends and Growth Forecast 2020-2025 - Cole of Duty - April 24th, 2020
- Mogrify and Sangamo in license agreement for 'off-the-shelf' CAR-Treg - BioPharma-Reporter.com - April 23rd, 2020
- Lozier praises promising, and ethical, blindness study - OneNewsNow - April 23rd, 2020
- A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer - Science Advances - April 23rd, 2020
- PHF20L1 as a H3K27me2 reader coordinates with transcriptional repressors to promote breast tumorigenesis - Science Advances - April 21st, 2020